LANSILA DDR 60MG CAP

LANSILA DDR 60MG CAP contains dexlanzoprazole, a delayed-release proton pump inhibitor designed to reduce stomach acid production. Each capsule delivers 60mg of the active ingredient in a dual delayed-release formulation for extended therapeutic effect. Indicated for the treatment of heartburn, acid reflux, and gastroesophageal reflux disease (GERD). The delayed-release mechanism ensures optimal absorption in the small intestine, providing sustained relief throughout the day. Suitable for adults requiring long-term acid suppression therapy. Take as directed by your healthcare provider, typically once daily. Store in a cool, dry place away from moisture and direct sunlight. Consult your doctor before use if you have liver disease, vitamin B12 deficiency, or are taking other medications. Not recommended during pregnancy without medical supervision.